title: Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease.
authors.affiliation: World Heart Federation, Geneva, Switzerland, and the London School of Hygiene & Tropical Medicine, London, United Kingdom. Electronic address: Pablo.Perel@worldheart.org.
authors.forename: Pablo
authors.initials: P
authors.lastname: Perel
authors.affiliation: Dante Pazzanese Institute of Cardiology, São Paulo, Brazil.
authors.forename: Alvaro
authors.initials: A
authors.lastname: Avezum
authors.affiliation: Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
authors.forename: Mark
authors.initials: M
authors.lastname: Huffman
authors.affiliation: St. John's Research Institute, Bangalore, India.
authors.forename: Prem
authors.initials: P
authors.lastname: Pais
authors.affiliation: The George Institute for Global Health, Sydney, New South Wales, Australia.
authors.forename: Anthony
authors.initials: A
authors.lastname: Rodgers
authors.forename: Rajesh
authors.initials: R
authors.lastname: Vedanthan
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, NY, USA.
authors.forename: Raj
authors.initials: R
authors.lastname: Vedanthan
authors.affiliation: International Centre for Circulatory Health, Imperial College London, London, United Kingdom.
authors.forename: David
authors.initials: D
authors.lastname: Wood
authors.affiliation: Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
authors.forename: Salim
authors.initials: S
authors.lastname: Yusuf
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000572:American Heart Association; D050197:Atherosclerosis / Q000401:mortality / Q000517:prevention & control*; D003324:Coronary Artery Disease / Q000401:mortality / Q000517:prevention & control*; D019049:Developed Countries; D003906:Developing Countries; D014943:Global Health; D017408:Guidelines as Topic; D006288:Health Planning Organizations / Q000592:standards; D006801:Humans; D009017:Morbidity; D020340:Tobacco Use Cessation; D014481:United States
chemical_list: D000319:Adrenergic beta-Antagonists